SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Audia, B. Godeau, B. Bonnotte, Is there still a place for “old therapies” in the management of immune thrombocytopenia?, La Revue de Médecine Interne, 2016, 37, 1, 43

    CrossRef

  2. 2
    Ashwin P. Patel, Amit S. Patil, Dapsone for immune thrombocytopenic purpura in children and adults, Platelets, 2015, 26, 2, 164

    CrossRef

  3. 3
    Thet Oo, Quentin A. Hill, Disappointing response to dapsone as second line therapy for primary ITP: a case series, Annals of Hematology, 2015, 94, 6, 1053

    CrossRef

  4. 4
    Guillaume Moulis, Maryse Lapeyre-Mestre, Jean-Louis Montastruc, Laurent Sailler, Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study, Autoimmunity Reviews, 2015, 14, 2, 168

    CrossRef

  5. 5
    G. Sauvetre, M. Mahevas, M. Khellaf, N. Limal, C. Guillaud Danis, L. Languille, P. Bierling, M. Michel, B. Godeau, Caractéristiques des toxidermies à la dapsone au cours du traitement d’un purpura thrombopénique immunologique. À propos d’une série monocentrique de 16 patients, La Revue de Médecine Interne, 2013, 34, A56

    CrossRef

  6. 6
    C. Rodrigo, L. Gooneratne, Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review, Journal of Thrombosis and Haemostasis, 2013, 11, 11
  7. 7
    S. Audia, M. Samson, M. Mahevas, C. Ferrand, M. Trad, M. Ciudad, A. Gautheron, F. Seaphanh, V. Leguy, S. Berthier, B. Salles, L. Martin, B. Lorcerie, P. Ortega-Deballon, O. Facy, D. Caillot, A. Soudry-Faure, M. Michel, B. Godeau, N. Larmonier, P. Saas, N. Janikashvili, B. Bonnotte, Preferential splenic CD8+ T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia, Blood, 2013, 122, 14, 2477

    CrossRef

  8. 8
    Souleymane Brah, Laurent Chiche, Raphaelle Fanciullino, Charléric Bornet, Julien Mancini, Nicolas Schleinitz, Rodolphe Jean, Gilles Kaplanski, Jean-Robert Harlé, Jean-Marc Durand, Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey, Annals of Hematology, 2012, 91, 2, 279

    CrossRef

  9. 9
    Joyce Generali, Dennis Cada, Off-Label Drug Uses - Dapsone (Adults): Idiopathic Thrombocytopenic Purpura (Primary Immune Thrombocytopenia), Hospital Pharmacy, 2011, 46, 6, 415

    CrossRef

  10. 10
    M. Khellaf, Prise en charge du purpura thrombopénique immunologique de l’adulte, La Revue de Médecine Interne, 2010, 31, S329

    CrossRef

  11. 11
    S. Audia, D. Lakomy, J. Guy, V. Leguy-Seguin, S. Berthier, S. Aho, B. Lorcerie, B. Bonnotte, Traitement du purpura thrombopénique immunologique : étude rétrospective de 40 patients, La Revue de Médecine Interne, 2010, 31, 5, 337

    CrossRef

  12. 12
    Jyoti D. Chouhan, Jon D. Herrington, Treatment Options for Chronic Refractory Idiopathic Thrombocytopenic Purpura in Adults: Focus on Romiplostim and Eltrombopag, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010, 30, 7
  13. 13
    B. Godeau, P. Bierling, Purpura thrombopénique auto-immun, EMC - Hématologie, 2008, 3, 2, 1

    CrossRef

  14. 14
    Bertrand Godeau, Philippe Bierling, Traitement du purpura thrombopénique auto-immun de l’adulte, La Presse Médicale, 2008, 37, 9, 1292

    CrossRef

  15. 15
    Bertrand Godeau, Drew Provan, James Bussel, Immune thrombocytopenic purpura in adults, Current Opinion in Hematology, 2007, 14, 5, 535

    CrossRef

  16. 16
    Klaus Lechner, Ansgar Weltermann, Ingrid Pabinger, Autoimmunthrombozytopenie (AITP) des Erwachsenen: Klinik, Diagnose und Therapie, Wiener klinische Wochenschrift, 2006, 118, 9-10, 255

    CrossRef

  17. 17
    James Bussel, Treatment of Immune Thrombocytopenic Purpura in Adults, Seminars in Hematology, 2006, 43, S3

    CrossRef

  18. 18
    B. H. CHONG, S.-J. HO, Autoimmune thrombocytopenia, Journal of Thrombosis and Haemostasis, 2005, 3, 8
  19. 19
    Sharat Damodar, Auro Viswabandya, Biju George, Vikram Mathews, Mammen Chandy, Alok Srivastava, Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults – a report on 90 patients, European Journal of Haematology, 2005, 75, 4
  20. 20
    Douglas B. Cines, Robert McMillan, Management of Adult Idiopathic Thrombocytopenic Purpura, Annual Review of Medicine, 2005, 56, 1, 425

    CrossRef

  21. 21
    S Gerald Sandler, S Osman Tutuncuoglu, Immune thrombocytopenic purpura – current management practices, Expert Opinion on Pharmacotherapy, 2004, 5, 12, 2515

    CrossRef

  22. 22
    Nathan D. Meeker, Robert Goldsby, Kelly R. Terrill, Kevin S. Delaney, William B. Slayton, Dapsone Therapy for Children With Immune Thrombocytopenic Purpura, Journal of Pediatric Hematology/Oncology, 2003, 25, 2, 173

    CrossRef

  23. 23
    Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy, British Journal of Haematology, 2003, 120, 4
  24. 24
    Joseph Schwartz, Melissa D. Leber, Shmuel Gillis, Austin Giunta, Amiram Eldor, James B. Bussel, Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP), American Journal of Hematology, 2003, 72, 2
  25. 25
    Drew Provan, Adrian Newland, Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults, British Journal of Haematology, 2002, 118, 4
  26. 26
    Douglas B. Cines, Victor S. Blanchette, Immune Thrombocytopenic Purpura, New England Journal of Medicine, 2002, 346, 13, 995

    CrossRef

  27. 27
    Nicholas P Webber, John O Mascarenhas, Mary K Crow, James Bussel, Elaine J Schattner, Functional properties of lymphocytes in idiopathic thrombocytopenic purpura, Human Immunology, 2001, 62, 12, 1346

    CrossRef

  28. 28
    Klaus Lechner, MANAGEMENTOF ADULT IMMUNE THROMBOCYTOPENIA, Reviews in Clinical and Experimental Hematology, 2001, 5, 3
  29. 29
    James N George, Kiarash Kojouri, Jedidiah J Perdue, Sara K Vesely, Management of patients with chronic, refractory idiopathic thrombocytopenic purpura, Seminars in Hematology, 2000, 37, 3, 290

    CrossRef

  30. 30
    R. LUSH, H. ILAND, B. PEAT, G. YOUNG, Successful use of dapsone in refractory pregnancy-associated idiopathic thrombocytopenic purpura, Australian and New Zealand Journal of Medicine, 2000, 30, 1
  31. 31
    F. RADAELLI, R. CALORI, M. GOLDANIGA, E. GUGGIARI, A. LUCIANO, ADULT REFRACTORY CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA: CAN DAPSONE BE PROPOSED AS SECOND-LINE THERAPY?, British Journal of Haematology, 1999, 104, 3
  32. 32
    H. Le Louët, M. Ruivart, P. Bierling, J.C. Duche, B. Godeau, Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura, American Journal of Hematology, 1999, 62, 4
  33. 33
    Shmuel Gillis, Amiram Eldor, 6 Immune thrombocytopenic purpura in adults: clinical aspects, Baillière's Clinical Haematology, 1998, 11, 2, 361

    CrossRef

  34. 34
    Kiyoshi Tsuji, Takashi Ogino, Nobuo Seki, Masae Sawada, Yu Sudo, Fusako Nishigaki, Toshitaka Manda, Massaki Matsuo, Synthesis and effects of novel thiazole derivatives against thrombocytopenia, Bioorganic & Medicinal Chemistry Letters, 1998, 8, 18, 2473

    CrossRef